Sanguine Biosciences, a leading provider of high-quality human biospecimens and real-world clinical data, today announced the ...

A photographic study of art and its audience, a bold anti-design portfolio, and a colorful impact report take top honors ...

For investment teams, the early gains from generative AI use have come from efficiency. But because these tools are now ...

Q4 2025 Earnings Call Transcript December 11, 2025 Ciena Corporation beats earnings expectations. Reported EPS is $0.91, ...

Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs December 7, 2025 ...

The Phase 3 STAR-221 study evaluating a domvanalimab-based combination in upper gastrointestinal cancers will be discontinued due to futilityArcus is continuing to expand its development program for ...

"With DoctorBox, we are gaining a strong partner that enables us to offer ColoAlert exactly where prevention can take place today - at home,” said Guido Baechler, CEO of Mainz Biomed. "Together, we ...

Q3-2025 Portfolio Highlights Subsequent to the nine months ended September 30, 2025, the Company announced that it had entered into a definitive option agreement with a wholly owned subsidiary of BHP ...

FREMONT, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a global high-performance battery company, today announced its participation in the following investor ...

MONTREAL / Dec 10, 2025 / Business Wire / Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) is pleased to announce the successful ...

The OkaiDx Detect Pancreatic Cancer test has not been cleared or approved by the U.S. Food and Drug Administration, results are from an independently conducted EG BioMed study and remain under ...

Falcon Gold Provides Corporate And Strategic Update On Canadian Portfolio. FG: TSXV 3FA: FRA Update covers permitting progress, project expansions, portfolio optimization, and strategic outlook ...